SARS-CoV-2 Antibodies in Unvaccinated Older Population and its Relationship with Hematological Parameters
DOI:
https://doi.org/10.35845/abms.2025.2.504Keywords:
Immunoglobulin-G, SARS COV-2, Seroprevalence, UnvaccinatedAbstract
OBJECTIVE: The objective of this study was to determine the prevalence of SARS-CoV-2 (Immunoglobulin-G) antibodies in unvaccinated older populations and their relationship with hematological parameters.
METHODOLOGY: The study was conducted from March to August 2022. Two-hundred forty six healthy unvaccinated individuals aged 60 and above were included by random sampling. Blood specimens were obtained to determine antibodies using the ECLIA technique. Data was analyzed with SPSS version 26.
RESULTS: The study showed that 170 (69.11%) participants were male, while 76 (30.89%) were female. Mean age of study sample was 67±6.9 (range:60-100) years. Participants were categorized into two age groups: Group I (60-69 years) had 163 (66.30%) participants, and Group II (70-100 years) had 83 (33.70%). IgG antibodies were positive in 225 (91.46%) participants and negative in 21 (8.54%). When considering gender, IgG was positive in 155/170 (91.17%) males and 70/76 (92.11%) females and negative in 15/170 (8.82%) males and 6/76 (7.89%) females. Regarding age groups, IgG was positive in 154/163 (94.48%) in Group I and 71/83 (85.54%) in Group II. No significant relationship was found between IgG and hematological parameters.
CONCLUSION: Our study showed a 91% prevalence of IgG antibodies in the older population. The seroprevalence of antibodies against SARS-CoV-2 in the older population has increased. However, they still need vaccination so that the risk of getting an infection can be minimized.
References
Jahangir MA, Muheem A, Rizvi MF. Coronavirus (COVID-19): history, current knowledge and pipeline medications. Int J Pharm Pharmacol 2020; 4: 140 doi: 1031531/2581. 2020;3080(2).
Abassi Z, Knaney Y, Karram T, Heyman SN. The lung macrophage in SARS-CoV-2 infection: a friend or a foe? Frontiers in Immunology. 2020;11:1312.
Tyagi SC, Singh M. Multi-organ damage by covid-19: congestive (cardio-pulmonary) heart failure, and blood-heart barrier leakage. Mol Cell Biochem. 2021 Apr;476(4):1891–5.
Asakura H, Ogawa H. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int J Hematol. 2021 Jan;113(1):45–57.
Jones DL, Baluja MQ, Graham DW, Corbishley A, McDonald JE, Malham SK, et al. Shedding of SARS- CoV-2 in feces and urine and its potential role in person-to-person transmission and the environment-based spread of COVID-19. Science of The Total Environment. 2020 Dec;749:141364.
Mungmunpuntipantip R, Wiwanitkit V. COVID-19, neurovascular thrombotic problem and short summary on blood coagulation disorder: a brief review. Egypt J Neurol Psychiatr Neurosurg. 2022;58(1):6.
Teimury A, Khameneh MT, Khaledi EM. Major coagulation disorders and parameters in COVID-19 patients. Eur J Med Res. 2022 Feb 15;27(1):25.
Martín MC, González MI, Holgado N, Jimenez AI, Ortega N, Page I, et al. SARS-CoV-2 seroprevalence and gender-related haematological features in asymptomatic blood donors. medRxiv. 2021
Fan BE, Chong VCL, Chan SSW, Lim GH, Lim KGE, Tan GB, et al. Hematologic parameters in patients with COVID-19 infection. Am J Hematol. 2020 Jun;95(6):E131–4
Elahi S. Hematopoietic responses to SARS-CoV-2 infection. Cell Mol Life Sci. 2022 Mar 13;79(3):187-9
Safiabadi Tali SH, LeBlanc JJ, Sadiq Z, Oyewunmi OD, Camargo C, Nikpour B, et al. Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection. Clin Microbiol Rev. 2023, 4(3):e00228-20.
Ceci FM, Fiore M, Gavaruzzi F, Angeloni A, Lucarelli M, Scagnolari C, et al. Early Routine Biomarkers of SARS-CoV-2 Morbidity and Mortality: Outcomes from an Emergency Section. Diagnostics. 2022;12(1):176.
Ling R, Yu Y, He J, Zhang J, Xu S, Sun R, Li T, Ji H, Wang H. Seroprevalence and epidemiological characteristics of immunoglobulin M and G antibodies against SARS-CoV-2 in asymptomatic people in Wuhan, China. medRxiv. 2020:2020-06.
Tyagi SC, Singh M. Multi-organ damage by covid-19: congestive (cardio-pulmonary) heart failure, and blood-heart barrier leakage. Mol Cell Biochem. 2021;476(4):1891–5.
Asakura H, Ogawa H. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int J Hematol. 2021;113(1):45–57.
Jones DL, Baluja MQ, Graham DW, Corbishley A, McDonald JE, Malham SK, et al. Shedding of SARS-CoV-2 in feces and urine and its potential role in person-to-person transmission and the environment-based spread of COVID-19. Sci Tot Envir. 2020;749:141364.
Abassi Z, Knaney Y, Karram T, Heyman SN. The lung macrophage in SARS-CoV-2 infection: a friend or a foe? Frontiers in Immunology. 2020;11:1312.
Yüce M, Filiztekin E, Özkaya KG. COVID-19 diagnosis —A review of current methods. Biosensors and Bioelectronics. 2021 Jan;172:112752.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 yasar mehmood Yousafzai, Zahir Shah, muhammad ihtesham khan, Muhammad Arif, Nazish Farooq
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may Share-copy and redistribute the material in any medium or format and Adapt-remix, transform, and build upon the material. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
. 
